Greg Kennelty

January 17, 2017

CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.

January 13, 2017

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

January 06, 2017

Sibylle Loibl, M.D., Ph.D., discusses the GeparSepto trial and what it means for women with breast cancer.

October 12, 2016

Michael Choti talks about what kind of advances can be expected in treating liver cancer, including PD-1 inhibitors and neoadjuvant treatment.

September 27, 2016

More advances, such as personalized approaches, still need to be made in treating glioblastoma, says Jennifer Moliterno Gunel, a brain surgeon from Yale.

September 19, 2016

Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer.

August 19, 2016

Eileen O'Reilly discusses the current barriers in treating pancreatic cancer, as well as what she sees for the future of the disease.

August 11, 2016

Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.

August 05, 2016

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

July 14, 2016

Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected.

July 12, 2016

A phase 2 study showed that abemaciclib may be a promising option for some patients with breast cancer.

June 27, 2016

Testing for BRCA mutations is an important step in developing the treatment plan for patients with breast cancer, says Leslie Randall.

June 03, 2016

What are the next steps for immunotherapy in RCC? CURE spoke with Mark Ball to find out.

June 02, 2016

The role of radiation continues to change for patients with breast cancer, especially for those over the age of 70, for whom radiation might not be the best option.

May 12, 2016

Many advances have been made regarding immunotherapy to treat melanoma, and there is also more to come, says Antoni Ribas.

April 13, 2016

Phase 3 studies are giving investigators hope that Lynparza (olaparib) will gain FDA approval for the treatment of ovarian cancer, according to Ursula A. Matulonis.

April 13, 2016

Immunotherapy for the treatment of NSCLC will eventually be used in all settings, according to Edward Kim.

March 21, 2016

March 10, 2016

With dedication to research and advocacy, the National Brain Tumor Society is making strides in treatment of brain cancer.

February 24, 2016

February 22, 2016

The coming years look promising for advances in treatment of pediatric brain cancer, according to Matthias A. Karajannis.

February 19, 2016

Andrew S. Chi discusses some of the exciting new advancements for treatment of brain cancer.